 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Gene regulation
|
PDB id
|
|
|
|
1cok
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
EMBO J
18:4438-4445
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain.
|
|
S.W.Chi,
A.Ayed,
C.H.Arrowsmith.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
p73 and p63 are two recently cloned genes with homology to the tumor suppressor
p53, whose protein product is a key transcriptional regulator of genes involved
in cell cycle arrest and apoptosis. While all three proteins share conserved
transcriptional activation, DNA-binding and oligomerization domains, p73 and p63
have an additional conserved C-terminal region. We have determined the
three-dimensional solution structure of this conserved C-terminal domain of
human p73. The structure reveals a small five-helix bundle with striking
similarity to the SAM (sterile alpha motif) domains of two ephrin receptor
tyrosine kinases. The SAM domain is a putative protein-protein interaction
domain found in a variety of cytoplasmic signaling proteins and has been shown
to form both homo- and hetero-oligomers. However, the SAM-like C-terminal
domains of p73 and p63 are monomeric and do not interact with one another,
suggesting that this domain may interact with additional, as yet uncharacterized
proteins in a signaling and/or regulatory role.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3 A backbone representation of the solution structure
residues 491–550 of p73. Residues 487–490 and 551–554 are
unstructured and are not displayed. (A) The superposition of the
18 lowest energy structures. Helices 1–5 are colored yellow,
green, cyan, pink and red, respectively. (B) A ribbon display of
a representative structure. The side chains are displayed for
conserved hydrophobic residues involved in the association of
the five helices: L497 (yellow); L500 (white); I506, F509
(green); L514 (white); L520 (blue); L528 (pink); and I541, W542,
L545 (red). Each of these residues corresponds to a hydrophonic
or aliphatic residue in the SAM domain consensus sequence
derived by Shultz et al. (1997). Graphics were generated with
InstightII. The atomic coordinates have been deposited in the
Protein Data Bank, accession number 1cok.
|
 |
Figure 5.
Figure 5 Representative sedimentation equilibrium data, fitted
curves and residuals for p73 C-terminal proteins. (A)
p73(487–554) (0.2 mg/ml, 22 500 r.p.m.). The apparent
molecular weight obtained from the fitting procedure was 9395 Da
(expected molecular weight for the mononer is 10 096 Da). (B)
p73(487–600) (0.5 mg/ml, 35 000 r.p.m.). The apparent
molecular weight obtained from the fitting procedure was 13 922
Da (expected molecular weight for the monomer is 15 124 Da).
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
EMBO J
(1999,
18,
4438-4445)
copyright 1999.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Coutandin,
H.Der Ou,
F.Löhr,
and
V.Dötsch
(2010).
Tracing the protectors path from the germ line to the genome.
|
| |
Proc Natl Acad Sci U S A, 107,
15318-15325.
|
 |
|
|
|
|
 |
A.Bhunia,
P.N.Domadia,
H.Mohanram,
and
S.Bhattacharjya
(2009).
NMR structural studies of the Ste11 SAM domain in the dodecyl phosphocholine micelle.
|
| |
Proteins, 74,
328-343.
|
 |
|
|
|
|
 |
A.D.Meruelo,
and
J.U.Bowie
(2009).
Identifying polymer-forming SAM domains.
|
| |
Proteins, 74,
1-5.
|
 |
|
|
|
|
 |
J.K.Nzoughet,
J.T.Hamilton,
C.H.Botting,
A.Douglas,
L.Devine,
J.Nelson,
and
C.T.Elliott
(2009).
Proteomics identification of azaspiracid toxin biomarkers in blue mussels, Mytilus edulis.
|
| |
Mol Cell Proteomics, 8,
1811-1822.
|
 |
|
|
|
|
 |
D.Antonini,
M.Dentice,
P.Mahtani,
L.De Rosa,
G.Della Gatta,
A.Mandinova,
D.Salvatore,
E.Stupka,
and
C.Missero
(2008).
Tprg, a gene predominantly expressed in skin, is a direct target of the transcription factor p63.
|
| |
J Invest Dermatol, 128,
1676-1685.
|
 |
|
|
|
|
 |
H.D.Ou,
F.Löhr,
V.Vogel,
W.Mäntele,
and
V.Dötsch
(2007).
Structural evolution of C-terminal domains in the p53 family.
|
| |
EMBO J, 26,
3463-3473.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Li,
K.L.Fung,
D.Y.Jin,
S.S.Chung,
Y.P.Ching,
I.O.Ng,
K.H.Sze,
B.C.Ko,
and
H.Sun
(2007).
Solution structures, dynamics, and lipid-binding of the sterile alpha-motif domain of the deleted in liver cancer 2.
|
| |
Proteins, 67,
1154-1166.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.P.Deyoung,
and
L.W.Ellisen
(2007).
p63 and p73 in human cancer: defining the network.
|
| |
Oncogene, 26,
5169-5183.
|
 |
|
|
|
|
 |
B.Testoni,
and
R.Mantovani
(2006).
Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63.
|
| |
Nucleic Acids Res, 34,
928-938.
|
 |
|
|
|
|
 |
L.Römer,
C.Klein,
A.Dehner,
H.Kessler,
and
J.Buchner
(2006).
p53--a natural cancer killer: structural insights and therapeutic concepts.
|
| |
Angew Chem Int Ed Engl, 45,
6440-6460.
|
 |
|
|
|
|
 |
T.Inoue,
K.Terada,
A.Furukawa,
C.Koike,
Y.Tamaki,
M.Araie,
and
T.Furukawa
(2006).
Cloning and characterization of mr-s, a novel SAM domain protein, predominantly expressed in retinal photoreceptor cells.
|
| |
BMC Dev Biol, 6,
15.
|
 |
|
|
|
|
 |
W.B.Jacobs,
D.R.Kaplan,
and
F.D.Miller
(2006).
The p53 family in nervous system development and disease.
|
| |
J Neurochem, 97,
1571-1584.
|
 |
|
|
|
|
 |
G.Liu,
and
X.Chen
(2005).
The C-terminal sterile alpha motif and the extreme C terminus regulate the transcriptional activity of the alpha isoform of p73.
|
| |
J Biol Chem, 280,
20111-20119.
|
 |
|
|
|
|
 |
M.Hosoda,
T.Ozaki,
K.Miyazaki,
S.Hayashi,
K.Furuya,
K.Watanabe,
T.Nakagawa,
T.Hanamoto,
S.Todo,
and
A.Nakagawara
(2005).
UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination.
|
| |
Oncogene, 24,
7156-7169.
|
 |
|
|
|
|
 |
M.I.Koster,
S.Kim,
and
D.R.Roop
(2005).
P63 deficiency: a failure of lineage commitment or stem cell maintenance?
|
| |
J Investig Dermatol Symp Proc, 10,
118-123.
|
 |
|
|
|
|
 |
S.Bhattacharjya,
P.Xu,
M.Chakrapani,
L.Johnston,
and
F.Ni
(2005).
Polymerization of the SAM domain of MAPKKK Ste11 from the budding yeast: implications for efficient signaling through the MAPK cascades.
|
| |
Protein Sci, 14,
828-835.
|
 |
|
|
|
|
 |
U.Nyman,
A.Sobczak-Pluta,
P.Vlachos,
T.Perlmann,
B.Zhivotovsky,
and
B.Joseph
(2005).
Full-length p73alpha represses drug-induced apoptosis in small cell lung carcinoma cells.
|
| |
J Biol Chem, 280,
34159-34169.
|
 |
|
|
|
|
 |
C.E.Tognon,
C.D.Mackereth,
A.M.Somasiri,
L.P.McIntosh,
and
P.H.Sorensen
(2004).
Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity.
|
| |
Mol Cell Biol, 24,
4636-4650.
|
 |
|
|
|
|
 |
G.Liu,
S.Nozell,
H.Xiao,
and
X.Chen
(2004).
DeltaNp73beta is active in transactivation and growth suppression.
|
| |
Mol Cell Biol, 24,
487-501.
|
 |
|
|
|
|
 |
K.A.Honeycutt,
M.I.Koster,
and
D.R.Roop
(2004).
Genes involved in stem cell fate decisions and commitment to differentiation play a role in skin disease.
|
| |
J Investig Dermatol Symp Proc, 9,
261-268.
|
 |
|
|
|
|
 |
M.I.Koster,
and
D.R.Roop
(2004).
p63 and epithelial appendage development.
|
| |
Differentiation, 72,
364-370.
|
 |
|
|
|
|
 |
S.J.Grimshaw,
H.R.Mott,
K.M.Stott,
P.R.Nielsen,
K.A.Evetts,
L.J.Hopkins,
D.Nietlispach,
and
D.Owen
(2004).
Structure of the sterile alpha motif (SAM) domain of the Saccharomyces cerevisiae mitogen-activated protein kinase pathway-modulating protein STE50 and analysis of its interaction with the STE11 SAM.
|
| |
J Biol Chem, 279,
2192-2201.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Fomenkov,
Y.P.Huang,
O.Topaloglu,
A.Brechman,
M.Osada,
T.Fomenkova,
E.Yuriditsky,
B.Trink,
D.Sidransky,
and
E.Ratovitski
(2003).
P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome.
|
| |
J Biol Chem, 278,
23906-23914.
|
 |
|
|
|
|
 |
B.R.Szymczyna,
J.Bowman,
S.McCracken,
A.Pineda-Lucena,
Y.Lu,
B.Cox,
M.Lambermon,
B.R.Graveley,
C.H.Arrowsmith,
and
B.J.Blencowe
(2003).
Structure and function of the PWI motif: a novel nucleic acid-binding domain that facilitates pre-mRNA processing.
|
| |
Genes Dev, 17,
461-475.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.N.Barrera,
J.A.Poveda,
J.M.González-Ros,
and
J.L.Neira
(2003).
Binding of the C-terminal sterile alpha motif (SAM) domain of human p73 to lipid membranes.
|
| |
J Biol Chem, 278,
46878-46885.
|
 |
|
|
|
|
 |
Huqun,
Y.Endo,
H.Xin,
M.Takahashi,
T.Nukiwa,
and
K.Hagiwara
(2003).
A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a dominant-negative function.
|
| |
Cancer Sci, 94,
718-724.
|
 |
|
|
|
|
 |
M.Ben-Yehoyada,
I.Ben-Dor,
and
Y.Shaul
(2003).
c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association.
|
| |
J Biol Chem, 278,
34475-34482.
|
 |
|
|
|
|
 |
M.D.Westfall,
D.J.Mays,
J.C.Sniezek,
and
J.A.Pietenpol
(2003).
The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.
|
| |
Mol Cell Biol, 23,
2264-2276.
|
 |
|
|
|
|
 |
T.Aviv,
Z.Lin,
S.Lau,
L.M.Rendl,
F.Sicheri,
and
C.A.Smibert
(2003).
The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators.
|
| |
Nat Struct Biol, 10,
614-621.
|
 |
|
|
|
|
 |
W.J.Freebern,
J.L.Smith,
S.S.Chaudhry,
C.M.Haggerty,
and
K.Gardner
(2003).
Novel cell-specific and dominant negative anti-apoptotic roles of p73 in transformed leukemia cells.
|
| |
J Biol Chem, 278,
2249-2255.
|
 |
|
|
|
|
 |
Y.P.Ching,
C.M.Wong,
S.F.Chan,
T.H.Leung,
D.C.Ng,
D.Y.Jin,
and
I.O.Ng
(2003).
Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.
|
| |
J Biol Chem, 278,
10824-10830.
|
 |
|
|
|
|
 |
A.Hackzell,
H.Uramoto,
H.Izumi,
K.Kohno,
and
K.Funa
(2002).
p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
|
| |
J Biol Chem, 277,
39769-39776.
|
 |
|
|
|
|
 |
A.Yang,
M.Kaghad,
D.Caput,
and
F.McKeon
(2002).
On the shoulders of giants: p63, p73 and the rise of p53.
|
| |
Trends Genet, 18,
90-95.
|
 |
|
|
|
|
 |
C.A.Kim,
M.Gingery,
R.M.Pilpa,
and
J.U.Bowie
(2002).
The SAM domain of polyhomeotic forms a helical polymer.
|
| |
Nat Struct Biol, 9,
453-457.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.N.Barrera,
M.T.Garzón,
J.Gómez,
and
J.L.Neira
(2002).
Equilibrium unfolding of the C-terminal SAM domain of p73.
|
| |
Biochemistry, 41,
5743-5753.
|
 |
|
|
|
|
 |
G.Melino,
V.De Laurenzi,
and
K.H.Vousden
(2002).
p73: Friend or foe in tumorigenesis.
|
| |
Nat Rev Cancer, 2,
605-615.
|
 |
|
|
|
|
 |
H.Nagaya,
I.Wada,
Y.J.Jia,
and
H.Kanoh
(2002).
Diacylglycerol kinase delta suppresses ER-to-Golgi traffic via its SAM and PH domains.
|
| |
Mol Biol Cell, 13,
302-316.
|
 |
|
|
|
|
 |
H.van Bokhoven,
and
H.G.Brunner
(2002).
Splitting p63.
|
| |
Am J Hum Genet, 71,
1.
|
 |
|
|
|
|
 |
K.Ohtakara,
M.Nishizawa,
I.Izawa,
Y.Hata,
S.Matsushima,
W.Taki,
H.Inada,
Y.Takai,
and
M.Inagaki
(2002).
Densin-180, a synaptic protein, links to PSD-95 through its direct interaction with MAGUIN-1.
|
| |
Genes Cells, 7,
1149-1160.
|
 |
|
|
|
|
 |
M.I.Koster,
K.A.Huntzinger,
and
D.R.Roop
(2002).
Epidermal differentiation: transgenic/knockout mouse models reveal genes involved in stem cell fate decisions and commitment to differentiation.
|
| |
J Investig Dermatol Symp Proc, 7,
41-45.
|
 |
|
|
|
|
 |
P.Ghioni,
F.Bolognese,
P.H.Duijf,
H.Van Bokhoven,
R.Mantovani,
and
L.Guerrini
(2002).
Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.
|
| |
Mol Cell Biol, 22,
8659-8668.
|
 |
|
|
|
|
 |
R.Ramachander,
C.A.Kim,
M.L.Phillips,
C.D.Mackereth,
C.D.Thanos,
L.P.McIntosh,
and
J.U.Bowie
(2002).
Oligomerization-dependent association of the SAM domains from Schizosaccharomyces pombe Byr2 and Ste4.
|
| |
J Biol Chem, 277,
39585-39593.
|
 |
|
|
|
|
 |
Z.Serber,
H.C.Lai,
A.Yang,
H.D.Ou,
M.S.Sigal,
A.E.Kelly,
B.D.Darimont,
P.H.Duijf,
H.Van Bokhoven,
F.McKeon,
and
V.Dötsch
(2002).
A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism.
|
| |
Mol Cell Biol, 22,
8601-8611.
|
 |
|
|
|
|
 |
C.A.Kim,
M.L.Phillips,
W.Kim,
M.Gingery,
H.H.Tran,
M.A.Robinson,
S.Faham,
and
J.U.Bowie
(2001).
Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression.
|
| |
EMBO J, 20,
4173-4182.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.A.Ratovitski,
M.Patturajan,
K.Hibi,
B.Trink,
K.Yamaguchi,
and
D.Sidransky
(2001).
p53 associates with and targets Delta Np63 into a protein degradation pathway.
|
| |
Proc Natl Acad Sci U S A, 98,
1817-1822.
|
 |
|
|
|
|
 |
H.G.Dohlman,
and
J.W.Thorner
(2001).
Regulation of G protein-initiated signal transduction in yeast: paradigms and principles.
|
| |
Annu Rev Biochem, 70,
703-754.
|
 |
|
|
|
|
 |
U.M.Moll,
S.Erster,
and
A.Zaika
(2001).
p53, p63 and p73--solos, alliances and feuds among family members.
|
| |
Biochim Biophys Acta, 1552,
47-59.
|
 |
|
|
|
|
 |
W.K.Wang,
M.Bycroft,
N.W.Foster,
A.M.Buckle,
A.R.Fersht,
and
Y.W.Chen
(2001).
Structure of the C-terminal sterile alpha-motif (SAM) domain of human p73 alpha.
|
| |
Acta Crystallogr D Biol Crystallogr, 57,
545-551.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.A.Lohrum,
and
K.H.Vousden
(2000).
Regulation and function of the p53-related proteins: same family, different rules.
|
| |
Trends Cell Biol, 10,
197-202.
|
 |
|
|
|
|
 |
M.C.Marin,
and
W.G.Kaelin
(2000).
p63 and p73: old members of a new family.
|
| |
Biochim Biophys Acta, 1470,
M93.
|
 |
|
|
|
|
 |
S.Ichimiya,
A.Nakagawara,
Y.Sakuma,
S.Kimura,
T.Ikeda,
M.Satoh,
N.Takahashi,
N.Sato,
and
M.Mori
(2000).
p73: structure and function.
|
| |
Pathol Int, 50,
589-593.
|
 |
|
|
|
|
 |
V.De Laurenzi,
G.Raschellá,
D.Barcaroli,
M.Annicchiarico-Petruzzelli,
M.Ranalli,
M.V.Catani,
B.Tanno,
A.Costanzo,
M.Levrero,
and
G.Melino
(2000).
Induction of neuronal differentiation by p73 in a neuroblastoma cell line.
|
| |
J Biol Chem, 275,
15226-15231.
|
 |
|
|
|
|
 |
W.K.Wang,
M.R.Proctor,
A.M.Buckle,
M.Bycroft,
and
Y.W.Chen
(2000).
Crystallization and preliminary crystallographic studies of a SAM domain at the C-terminus of human p73alpha.
|
| |
Acta Crystallogr D Biol Crystallogr, 56,
769-771.
|
 |
|
|
|
|
 |
X.Shao,
and
N.V.Grishin
(2000).
Common fold in helix-hairpin-helix proteins.
|
| |
Nucleic Acids Res, 28,
2643-2650.
|
 |
|
|
|
|
 |
Y.W.Chen,
E.J.Dodson,
and
G.J.Kleywegt
(2000).
Does NMR mean "not for molecular replacement"? Using NMR-based search models to solve protein crystal structures.
|
| |
Structure, 8,
R213-R220.
|
 |
|
|
|
|
 |
C.D.Thanos,
S.Faham,
K.E.Goodwill,
D.Cascio,
M.Phillips,
and
J.U.Bowie
(1999).
Monomeric structure of the human EphB2 sterile alpha motif domain.
|
| |
J Biol Chem, 274,
37301-37306.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.U.Schallreuter,
J.Moore,
J.M.Wood,
W.D.Beazley,
D.C.Gaze,
D.J.Tobin,
H.S.Marshall,
A.Panske,
E.Panzig,
and
N.A.Hibberts
(1999).
In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase.
|
| |
J Investig Dermatol Symp Proc, 4,
91-96.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|